Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

7.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.5K
Hypoxia01:23

Hypoxia

2.6K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.6K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

4.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.4K
Master Transcription Regulators02:23

Master Transcription Regulators

8.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histological Analysis of Cryopreserved Venous Allografts Used for Liver Transplantation and Hepato-Biliary-Pancreatic Surgery.

Journal of hepato-biliary-pancreatic sciences·2026
Same author

Plasma 5-Fluorouracil Exposure, Clinical Outcomes, and Therapeutic Drug Monitoring in Advanced Colorectal Cancer.

Cancers·2026
Same author

Skeletal editing via multi-step engineering of a modular polyketide synthase.

Nature communications·2026
Same author

JCS 2026 Guideline on Management of Large Vessel Vasculitis.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Association between Changes in Stent Graft Volume and Type II Endoleaks after Endovascular Aneurysm Repair.

Annals of vascular diseases·2026
Same author

Pre-pregnancy body mass index and neonatal body weight in Japanese women with gestational diabetes mellitus: Hamamatsu GRACE Study 1.

Endocrine journal·2026

Related Experiment Video

Updated: Apr 12, 2026

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

18.9K

Hypoxia-inducible factor as an angiogenic master switch.

Takuya Hashimoto1, Futoshi Shibasaki2

  • 1Department of Surgery, Yale University School of Medicine , New Haven, CT , USA ; Division of Vascular Surgery, Department of Surgery, Graduate School of Medicine, The University of Tokyo , Tokyo , Japan.

Frontiers in Pediatrics
|May 13, 2015
PubMed
Summary

Targeting hypoxia-inducible factors (HIFs) with eIF3e/INT6 siRNA offers a novel therapeutic angiogenesis strategy. This approach stabilizes HIF-2α, promoting blood vessel formation and reducing ischemic damage in preclinical models.

Keywords:
HIF-1αHIF-2αInt6/eIF3eangiogenesiscollateral vesselpVHLperipheral arterial disease

More Related Videos

Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

86.8K
Induction of Hypoxia in Living Frog and Zebrafish Embryos
08:01

Induction of Hypoxia in Living Frog and Zebrafish Embryos

Published on: June 26, 2017

10.3K

Related Experiment Videos

Last Updated: Apr 12, 2026

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

18.9K
Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

86.8K
Induction of Hypoxia in Living Frog and Zebrafish Embryos
08:01

Induction of Hypoxia in Living Frog and Zebrafish Embryos

Published on: June 26, 2017

10.3K

Area of Science:

  • Molecular Biology
  • Vascular Biology
  • Medical Research

Background:

  • Hypoxia-inducible factors (HIFs) are key regulators of cellular response to low oxygen.
  • HIFs are implicated in vascular diseases and cancer, with potential roles in ischemic conditions.
  • Current therapeutic angiogenesis strategies using single growth factors have shown limited success.

Purpose of the Study:

  • To explore novel strategies for therapeutic angiogenesis by manipulating HIF activity.
  • To investigate the role of eIF3e/INT6 in regulating HIF-2α stability and its potential for treating ischemic diseases.

Main Methods:

  • Investigated the interaction between eIF3e/INT6 and HIF-2α.
  • Utilized eIF3e/INT6 siRNA to stabilize HIF-2α under normoxic conditions.
  • Assessed the induction of angiogenic factors and functional vessel formation in vivo.
  • Evaluated the efficacy of eIF3e/INT6 siRNA in animal models of ischemic injury.

Main Results:

  • eIF3e/INT6 specifically interacts with HIF-2α, promoting its degradation.
  • siRNA-mediated inhibition of eIF3e/INT6 stabilizes HIF-2α, inducing expression of multiple angiogenic factors.
  • This stabilization led to the formation of functional arteries and veins in vivo.
  • Administration of eIF3e/INT6 siRNA reduced ischemic damage in limb and brain injury models.

Conclusions:

  • Targeting the eIF3e/INT6-HIF-2α interaction presents a promising approach for therapeutic angiogenesis.
  • Stabilizing HIF-2α via oxygen-independent regulators offers a superior strategy for treating ischemic diseases.
  • This method holds potential for developing more effective treatments for conditions like arterial obstruction.